Same Indication

Nicotine Polacrilex vs Nivolumab

Nicotine Polacrilex vs Nivolumab: Overview

This comparison examines the pharmacological differences between Nicotine Polacrilex and Nivolumab.

Mechanism of Action

Nivolumab: Fully human anti-PD-1 IgG4 monoclonal antibody restoring T-cell anti-tumor activity.

Pharmacokinetics

Half-life: Nivolumab — 27 days.

Chemical Properties

Type: Nicotine Polacrilex — Unknown; Nivolumab — Antibody.